Regeneron Pharmaceuticals Inc
XBER:RGO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
R
|
Regeneron Pharmaceuticals Inc
XBER:RGO
|
US |
|
H
|
Hokuetsu Corp
DUS:HPE
|
JP |
|
B
|
Bloom Energy Corp
SWB:1ZB
|
US |
|
P
|
Pultegroup Inc
DUS:PU7
|
US |
|
C
|
Campbell Soup Co
LSE:0HST
|
US |
|
D
|
DaVita Inc
XBER:TRL
|
US |
|
S
|
SBFC Finance Ltd
NSE:SBFC
|
IN |
|
P
|
Pultegroup Inc
XMUN:PU7
|
US |
|
P
|
Patterson-UTI Energy Inc
DUS:PE1
|
US |
|
B
|
British American Tobacco PLC
SWB:BMTA
|
UK |
|
D
|
Dillard's Inc
F:DL7A
|
US |
|
J
|
Jabil Inc
XMUN:JBL
|
US |
|
A
|
Applied Industrial Technologies Inc
XBER:AT4
|
US |
|
Jacquet Metals SA
LSE:0IN3
|
FR |
|
Q
|
Qingdao Port International Co Ltd
F:0QP
|
CN |
|
A
|
Alpha Services and Holdings SA
XBER:ACBB
|
GR |
|
Liberty Media Corp
NASDAQ:FWONK
|
US |
|
M
|
Macy's Inc
F:FDO
|
US |
|
N
|
Nexon Co Ltd
F:7NX
|
JP |
|
C
|
Colgate-Palmolive Co
XETRA:CPA
|
US |
|
S
|
SoftBank Corp
SWB:3AG1
|
JP |
|
E
|
Eli Lilly and Co
XMUN:LLY
|
US |
|
E
|
eBay Inc
XHAM:EBA
|
US |
|
Skechers USA Inc
NYSE:SKX
|
US |
Wall St Price Targets
RGO Price Targets Summary
Regeneron Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for RGO is 172.57 EUR with a low forecast of 131.9 EUR and a high forecast of 213.92 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is RGO's stock price target?
Price Target
172.57
EUR
According to Wall Street analysts, the average 1-year price target for RGO is 172.57 EUR with a low forecast of 131.9 EUR and a high forecast of 213.92 EUR.
What is the Revenue forecast for Regeneron Pharmaceuticals Inc?
Projected CAGR
11%
Over the last 14 years, the compound annual growth rate for Revenue has been 28%. The projected CAGR for the next 3 years is 11%.
What is the Gross Profit forecast for Regeneron Pharmaceuticals Inc?
Projected CAGR
13%
Over the last 14 years, the compound annual growth rate for Gross Profit has been 27%. The projected CAGR for the next 3 years is 13%.
What is the Operating Income forecast for Regeneron Pharmaceuticals Inc?
Projected CAGR
23%
The compound annual growth rate for Operating Income over the next 3 years is 23%.
What is the Pre-Tax Income forecast for Regeneron Pharmaceuticals Inc?
Projected CAGR
15%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 15%.
What is the Net Income forecast for Regeneron Pharmaceuticals Inc?
Projected CAGR
15%
The compound annual growth rate for Net Income over the next 3 years is 15%.
